Securian Asset Management Inc. Sells 5,090 Shares of Xylem Inc. $XYL

Securian Asset Management Inc. cut its position in Xylem Inc. (NYSE:XYL) by 43.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,580 shares of the industrial products company’s stock after selling 5,090 shares during the quarter. Securian Asset Management Inc.’s holdings in Xylem were worth $896,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. State of Wyoming lifted its stake in Xylem by 10.4% in the third quarter. State of Wyoming now owns 756 shares of the industrial products company’s stock valued at $112,000 after acquiring an additional 71 shares during the last quarter. Orion Porfolio Solutions LLC raised its holdings in shares of Xylem by 1.0% in the 3rd quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock valued at $1,151,000 after purchasing an additional 74 shares during the period. Journey Strategic Wealth LLC lifted its stake in Xylem by 1.5% in the 3rd quarter. Journey Strategic Wealth LLC now owns 5,107 shares of the industrial products company’s stock valued at $753,000 after purchasing an additional 77 shares during the last quarter. Quest Investment Management LLC lifted its stake in Xylem by 1.0% in the 3rd quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock valued at $1,119,000 after purchasing an additional 77 shares during the last quarter. Finally, Keel Point LLC grew its holdings in Xylem by 4.6% during the third quarter. Keel Point LLC now owns 1,784 shares of the industrial products company’s stock worth $263,000 after purchasing an additional 79 shares during the period. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have issued reports on XYL. Oppenheimer dropped their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 29th. UBS Group lifted their target price on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Barclays decreased their target price on Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a report on Wednesday, April 29th. JPMorgan Chase & Co. cut their price target on Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. Finally, Robert W. Baird set a $161.00 price objective on shares of Xylem in a research report on Wednesday, February 11th. Seven analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, Xylem currently has a consensus rating of “Moderate Buy” and an average price target of $152.77.

Insider Buying and Selling

In related news, Director Jerome A. Peribere purchased 1,210 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The stock was acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the purchase, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. This represents a 4.65% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total value of $501,436.74. Following the sale, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. This represents a 54.22% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.32% of the company’s stock.

Xylem Trading Down 2.2%

Shares of Xylem stock opened at $109.09 on Thursday. The firm has a 50-day moving average of $121.18 and a 200-day moving average of $133.10. The stock has a market cap of $25.93 billion, a PE ratio of 27.14, a PEG ratio of 1.59 and a beta of 1.08. Xylem Inc. has a 52-week low of $108.96 and a 52-week high of $154.27. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The business had revenue of $2.13 billion for the quarter, compared to the consensus estimate of $2.11 billion. During the same period in the prior year, the company posted $1.03 earnings per share. Xylem’s revenue was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, sell-side analysts forecast that Xylem Inc. will post 5.51 EPS for the current year.

Xylem announced that its board has initiated a stock repurchase program on Wednesday, February 25th that authorizes the company to buyback $1.50 billion in outstanding shares. This buyback authorization authorizes the industrial products company to repurchase up to 4.8% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board believes its stock is undervalued.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.